Another post based on another of my research proposal...
There are several anticancer drugs made from precursors obtained from plant extracts..lets see one of them..
Podophyllotoxin is an important natural lignin, used as a precursor for
the synthesis of effective anticancer drugs like etoposide and teniposide which
are used in the treatment of lung cancer, testicular cancer, a variety of
leukemias and other tumours. It is a pharmaceutically active cytotoxin which
acts by inhibiting the assembly of microtubules, leading to arrestation of cell
division in the metaphase stage of mitosis. Due to its detrimental side-effects
in natural form, its derivatives were synthesized which were produced into FDA
approved drugs like etoposide, etc. Podophyllotoxin is also the precursor of
novel drugs aimed to treat diseases like rheumatoid arthritis, veneral warts,
measles, herpes, etc. Thus it is a very important natural drug. But, its
commercially exploitable plant sources are few. One of the few exploitable
species is Podophyllum hexandrum
Royle or the Indian Podophyllum, a perennial rhizome found in the Himalayas. It
has slow growth phase and is considered a 'critically endangered' plant. Also,
total chemical synthesis of podophyllotoxin is complicated and expensive. Thus,
several biotechnological approaches especially plant cell cultures have been
attempted and recorded.
Many research papers record attempts being made to improve the
accumulation of podophyllotoxin in in
vitro cultures by optimizing culture conditions and nutrient levels,
addition of elicitors and precursors, immobilization, etc. with varied success.
Bioreactor scale production represents the final stage leading to
commercial production. Although a number of important phytochemicals have been
produced by plant cell culture techniques, production on an industrial scale is
still not extensive. Major factors that need to be focused on are: increasing
the rate of growth of plant cells, production of a genetically stable cell
line, optimization of sterilization procedure, meeting oxygen demand without
hampering the process, prevention of shear, growth and production media
optimization, type of reactor, inoculum density, etc.
Works reviewed:
11)
Majumder A, Jha S, “Biotechnological Approaches for
the Production of Potential Anticancer leads Podophyllotoxin and Paclitaxel: an
Overview”, e Journal of Biological Sciences, 2009, Dec; Volume 1, Issue 1.
22)
Farkya S, Bisaria VS, Srivastava AK, “Biotechnological Aspects of the Production of the
Anticancer Drug Podophyllotoxin”, Appl Microbiol Biotechnol, 2004, Oct; 65(5):504-19. Epub 2004, Jul 28.